Robotics were the hot topic at NASS 2018, but discussions also raged about advanced implant materials that have the potential to promote better bone growth and faster healing and reduce reliance on expensive biologics to achieve those goals. An excerpt from Senior Writer Wendy Diller’s November 16 feature, “At NASS 2018, Advanced Biomaterials and the Pull of Robots.”
NASS, the year’s biggest spine surgery gathering, begins next week in Los Angeles amid a hot medtech financing market and tides of disruption—if a slow-shifting market like spine can be disrupted. We’ve put together a crib sheet on the key trends in M&A and R&D we will be watching for at the meeting, based on interviews in recent months with leading spine surgeons, analysts, and industry execs.
An interview with Dr. Bernard Prendergast, director of PCR’s London Valves meeting, who points out how innovation in cardiology is rapidly changing worldwide to include technologies like digital health and AI, and even areas like bioresorbable scaffolds, which some thought dead, hold exciting prospects for the future.